Risk Factors for Fibrosing Colonopathy in Cystic Fibrosis Patients


Clinical Trial

Offered by: Nemours
Location: Orlando, FL

Trial Name

Risk Factors for Fibrosing Colonopathy in U.S. Patients With Cystic Fibrosis Treated With Pancreatic Enzyme Replacement Therapy

What is the trial about?

To study risk factors for fibrosing colonopathy in patients with Cystic Fibrosis

Who can participate?

  • Diagnosis of Cystic Fibrosis
  • Enrolled in the Port CF Registry
  • Suspected diagnosis of Fibrosing Colonopath

What is involved?

Participation in this study will not require any additional time beyond the informed consent process.

Contact Nemours Clinical Trials

Trial Name: Risk Factors for Fibrosing Colonopathy in U.S. Patients With Cystic Fibrosis Treated With Pancreatic Enzyme Replacement Therapy

Contact Information

(800) 354-5690
clinicaltrials@nemours.org